NO822053L - Fremgangsmaate for fremstilling av nye cefemforbindelser, samt farmasoeytisk akseptable salter derav - Google Patents

Fremgangsmaate for fremstilling av nye cefemforbindelser, samt farmasoeytisk akseptable salter derav

Info

Publication number
NO822053L
NO822053L NO822053A NO822053A NO822053L NO 822053 L NO822053 L NO 822053L NO 822053 A NO822053 A NO 822053A NO 822053 A NO822053 A NO 822053A NO 822053 L NO822053 L NO 822053L
Authority
NO
Norway
Prior art keywords
amino
compound
general formula
salt
lower alkyl
Prior art date
Application number
NO822053A
Other languages
English (en)
Norwegian (no)
Inventor
Tsutomu Teraji
Kazuo Sakane
Jiro Goto
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Publication of NO822053L publication Critical patent/NO822053L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/70Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/61Halogen atoms or nitro radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/73Unsubstituted amino or imino radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D285/00Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01Five-membered rings
    • C07D285/02Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/081,2,4-Thiadiazoles; Hydrogenated 1,2,4-thiadiazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO822053A 1981-06-22 1982-06-21 Fremgangsmaate for fremstilling av nye cefemforbindelser, samt farmasoeytisk akseptable salter derav NO822053L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB8119173 1981-06-22
GB8129325 1981-09-29
GB8212051 1982-04-26

Publications (1)

Publication Number Publication Date
NO822053L true NO822053L (no) 1982-12-23

Family

ID=27261211

Family Applications (1)

Application Number Title Priority Date Filing Date
NO822053A NO822053L (no) 1981-06-22 1982-06-21 Fremgangsmaate for fremstilling av nye cefemforbindelser, samt farmasoeytisk akseptable salter derav

Country Status (11)

Country Link
US (1) US4495182A (fr)
EP (1) EP0069872B1 (fr)
KR (1) KR840000563A (fr)
AU (1) AU8420482A (fr)
DE (1) DE3277534D1 (fr)
DK (1) DK276582A (fr)
ES (1) ES8307824A1 (fr)
FI (1) FI822043L (fr)
GR (1) GR75487B (fr)
NO (1) NO822053L (fr)
PT (1) PT75066B (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4546101A (en) * 1982-09-10 1985-10-08 Fujisawa Pharmaceutical Co., Ltd. New cephem compounds useful for treating infectious diseases in human being and animals and processes for preparation thereof
US4785090A (en) * 1984-02-23 1988-11-15 Meiji Seika Kaisha, Ltd. Cephalosporin derivatives
US4880797A (en) * 1986-03-20 1989-11-14 Banyu Pharmaceutical Co., Ltd. Cephalosporin derivatives and antibacterial agents
CA1293719C (fr) * 1986-09-22 1991-12-31 Takao Takaya Composes de cephem et procede de preparation
KR100449775B1 (ko) * 1995-11-28 2005-08-17 동아제약주식회사 신규세팔로스포린유도체및그중간체
NZ564743A (en) * 2005-07-11 2010-03-26 Mitsubishi Tanabe Pharma Corp An oxime derivative as a glucokinase activating agent and preparations thereof
CA2848012A1 (fr) 2011-09-09 2013-03-14 Cubist Pharmaceuticals, Inc. Procedes de traitement d'infections intrapulmonaires
US8809314B1 (en) 2012-09-07 2014-08-19 Cubist Pharmacueticals, Inc. Cephalosporin compound
US8476425B1 (en) 2012-09-27 2013-07-02 Cubist Pharmaceuticals, Inc. Tazobactam arginine compositions
US9320740B2 (en) 2013-03-15 2016-04-26 Merck Sharp & Dohme Corp. Ceftolozane-tazobactam pharmaceutical compositions
MX2020004205A (es) 2013-03-15 2021-11-16 Merck Sharp & Dohme Llc Composiciones antibioticas de ceftolozano.
US9872906B2 (en) 2013-03-15 2018-01-23 Merck Sharp & Dohme Corp. Ceftolozane antibiotic compositions
JP6327754B2 (ja) 2013-06-21 2018-05-23 クミアイ化学工業株式会社 2−アミノ−2−ヒドロキシイミノ−n−アルコキシアセトイミドイルシアニドの製造方法およびその製造中間体
AU2014233637A1 (en) 2013-09-09 2015-03-26 Merck Sharp & Dohme Corp. Treating infections with ceftolozane/tazobactam in subjects having impaired renal function
US8906898B1 (en) 2013-09-27 2014-12-09 Calixa Therapeutics, Inc. Solid forms of ceftolozane
KR102285444B1 (ko) * 2019-11-19 2021-08-03 삼우시스템 (주) 메탈필터를 적용한 지하공간 자동재생형 공기정화장치
KR102366962B1 (ko) * 2020-08-10 2022-02-23 주식회사 포스코 송풍기 에어필터의 이물 제거장치

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1592149A (en) * 1976-10-08 1981-07-01 Fujisawa Pharmaceutical Co 3 7-disubstituted-3-cephem-4-carboxylic acid compounds and processes for preparation thereof
JPS53144594A (en) * 1976-12-27 1978-12-15 Fujisawa Pharmaceut Co Ltd 3,7-di-substitued-3-cephem-4-carboxylic acid derivatives
AR231986A1 (es) * 1978-05-26 1985-04-30 Glaxo Group Ltd Procedimiento para preparar antibioticos de cefalosporina
AR228726A1 (es) * 1978-05-26 1983-04-15 Glaxo Group Ltd Procedimiento para la preparacion del antibiotico(6r,7r)-7-((z)-2-(2-aminotiazol-4-il)-2-(2-carboxiprop-2-oxiimino)acetamido)-3-(1-piridiniometil)cef-3-em-4-carboxilato
US4332798A (en) * 1978-12-29 1982-06-01 Fujisawa Pharmaceutical Co., Ltd. 7-Amino-thia-diazole oxyimino derivatives of cephem and cephem compounds
NZ193212A (en) * 1979-03-22 1982-12-07 Glaxo Group Ltd Cephalosporin antibiotics and pharmaceutical compsitions
FI802107A (fi) * 1979-07-05 1981-01-06 Ciba Geigy Ag Aminotiadiazolylfoereningar foerfarande foer deras framstaellning farmaceutiska preparat som innehaoller saodana foereningar och anvaendning av de sistnaemda
US4381299A (en) * 1980-03-07 1983-04-26 Fujisawa Pharmaceutical Co., Ltd. 7-Amino-thiadiazole oxyimino derivatives of cephem and cepham compounds

Also Published As

Publication number Publication date
EP0069872B1 (fr) 1987-10-28
FI822043L (fi) 1982-12-23
DK276582A (da) 1982-12-23
GR75487B (fr) 1984-07-23
AU8420482A (en) 1983-01-06
PT75066A (en) 1982-07-01
EP0069872A3 (en) 1983-12-07
EP0069872A2 (fr) 1983-01-19
US4495182A (en) 1985-01-22
FI822043A0 (fi) 1982-06-09
PT75066B (en) 1983-12-28
DE3277534D1 (en) 1987-12-03
KR840000563A (ko) 1984-02-25
ES513296A0 (es) 1983-08-01
ES8307824A1 (es) 1983-08-01

Similar Documents

Publication Publication Date Title
NO822053L (no) Fremgangsmaate for fremstilling av nye cefemforbindelser, samt farmasoeytisk akseptable salter derav
DK162391B (da) Analogifremgangsmaade til fremstilling af syn-isomerer af 3,7-disubstituerede 3-cephem-4-carboxylsyreforbindelser
US4521413A (en) Cephem compounds
CH661733A5 (de) Cephemverbindungen und verfahren zu ihrer herstellung.
NO834463L (no) Fremgangsmaate til fremstilling av nye cefem-forbindelser
EP0099553B1 (fr) Dérivés de céphems, leur procédé de synthése et les intermédiaires de préparation, ainsi que les compositions pharmaceutiques les contenants
EP0184227B1 (fr) Dérivés de l'acide 2-oxymino-2-aminothiazolyl acétique et procédé de préparation
JPH0354111B2 (fr)
SE450384B (sv) Nya cefemforeningar och forfarande for deras framstellning
FI93732B (fi) Menetelmä valmistaa farmakologisesti arvokasta kefeemiyhdistettä
EP0027599B1 (fr) Dérivés de céphalosporine, leur préparation et compositions pharmaceutiques les contenant
NO812050L (no) Fremgangsmaate for fremstilling av farmakologisk aktive cefemforbindelser.
JPH0242829B2 (fr)
EP0010313B1 (fr) Composés d'acides 2- ou 3-céphème-4-carboxyliques, 3,7-disubstitués, compositions pharmaceutiques les contenant et procédés pour leur préparation
JPS58164594A (ja) 7―アシルアミノ―3―セフェム―4―カルボン酸誘導体
US4332800A (en) Cephem compounds
US4405617A (en) 3-(Propynyltetrazol)thiomethyl-3-cephems
US4443443A (en) Cephem compounds
CH659074A5 (de) Cephemverbindungen und verfahren zur herstellung derselben.
GB2033377A (en) New Cephem Compounds and Processes for Preparation Thereof
JPH0359076B2 (fr)
JP2518546B2 (ja) 新規セフェム化合物
NO813200L (no) Fremgangsmaate for fremstilling av antimikrobielle cefem-forbindelser.
BE897719A (fr) Procede de preparation de composes de cephem et nouveaux produits ainsi que les compositions pharmaceutiques les renfermant
US4408042A (en) Cephem compounds